This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Effect of Turmeric on Pruritus in Hemodialysis Patients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Maryam Pakfetrat, Shiraz University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT01037595
First received: December 22, 2009
Last updated: May 12, 2013
Last verified: May 2013
December 22, 2009
May 12, 2013
September 2010
October 2010   (Final data collection date for primary outcome measure)
improvement in pruritus [ Time Frame: 6 mo ]
Same as current
Complete list of historical versions of study NCT01037595 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Effect of Turmeric on Pruritus in Hemodialysis Patients
Not Provided
The purpose of this study is to see whether turmeric can be effective in treatment of pruritus in hemodialysis patients.
pruritus is a common in hemodialysis patients and many treatment recommended for it . as turmeric has anti-inflammatory , anti-cytokine and anti-oxidant effect it may effective in treatment of uremic pruritus. thus we compared turmeric with placebo in this study
Interventional
Early Phase 1
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Investigator)
Primary Purpose: Treatment
End Stage Renal Failure
  • Drug: turmeric
    turmeric 500 md tid orally for 8 weeks
  • Drug: placebo
    placebo 3 time orally for 8 weeks
  • Drug: turmeric
    500 mg tid orally for 8 weeks
  • Experimental: turmeric
    turmeric 500 mg tid orally for 8 weeks
    Interventions:
    • Drug: turmeric
    • Drug: turmeric
  • Placebo Comparator: plasebo
    placebo tid orally for 8 weeks
    Intervention: Drug: placebo
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
60
December 2010
October 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Hemodialysis for more than 3 months
  • More than 18 years old
  • Pruritus

Exclusion Criteria:

  • Use other treatment for pruritus
Sexes Eligible for Study: All
18 Years to 70 Years   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Iran, Islamic Republic of
 
 
NCT01037595
3441
No
Not Provided
Not Provided
Maryam Pakfetrat, Shiraz University of Medical Sciences
Shiraz University of Medical Sciences
Not Provided
Not Provided
Shiraz University of Medical Sciences
May 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP